Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma

Although immunotherapy with Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTLs) can treat EBV-associated Hodgkin and non-Hodgkin lymphoma (HL/NHL), more than 50% of such tumors are EBV negative. We now describe an approach that allows us to consistently generate, in a single line, CTLs...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Gerdemann, Ulrike, Katari, Usha, Christin, Anne S, Cruz, Conrad R, Tripic, Tamara, Rousseau, Alexandra, Gottschalk, Stephen M, Savoldo, Barbara, Vera, Juan F, Heslop, Helen E, Brenner, Malcolm K, Bollard, Catherine M, Rooney, Cliona M, Leen, Ann M
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2011
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3242656/
https://ncbi.nlm.nih.gov/pubmed/21915103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.167
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg